BrUOG-PA-205 A phase I trial of GW572016 [lapatinib], gemcitabine and oxaliplatin for metastatic pancreaticobiliary cancer schema GSK study protocolGSK-103556

Trial Profile

BrUOG-PA-205 A phase I trial of GW572016 [lapatinib], gemcitabine and oxaliplatin for metastatic pancreaticobiliary cancer schema GSK study protocolGSK-103556

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2014

At a glance

  • Drugs Lapatinib (Primary) ; Gemcitabine; Oxaliplatin
  • Indications Biliary cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Mar 2009 Actual end date changed from Feb 2007 to Dec 2007 as reported by ClinicalTrials.gov.
    • 15 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 31 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top